Noninvasive Quantification of Tumor Volume in Preclinical Liver Metastasis Models Using Contrast-Enhanced X-Ray Computed Tomography

Objectives:To determine a timepoint after contrast injection that yields equal liver parenchymal and vascular enhancement in micro-computed tomography images. To evaluate the utility of images acquired during this time period for the noninvasive measurement of liver-tumor volume. Materials and Methods:The imaging timepoint was determined by quantifying the enhancement kinetics of Fenestra VC (0.015 mL/g) in NIH III mice. In respiratory-gated images of tumor bearing mice, the ability to measure tumor volume was evaluated with a measurement variability study, and by comparing in vivo and histologically measured tumor volume. Results:Eight hours after contrast injection the liver parenchyma and vasculature were equally enhanced allowing for clear delineation of the unenhanced tumors. The smallest tumor detected in this study was 1.1 mm in diameter. The coefficient of variation for tumor-volume measurement ranged from 3.6% to 12.9% and from 6.3% to 25.8% for intra and interobserver variability, respectively. In vivo and histologic tumor-volume measurements were closely correlated (r = 0.98, P < 0.0001). Conclusions:Imaging at a time period of equal liver parenchyma and vascular enhancement after contrast injection allows for clear delineation of liver-tumor borders, thereby enabling quantitative tumor-volume monitoring.

[1]  M E Easterly,et al.  A review of high-resolution X-ray computed tomography and other imaging modalities for small animal research. , 2001, Lab animal.

[2]  Robert M Hoffman,et al.  High correlation of whole-body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer. , 2005, Cancer research.

[3]  Erik L. Ritman,et al.  Quantitative Imaging of Microvascular Permeability in a Rat Model of Lipopolysaccharide-Induced Sepsis: Evaluation Using Cryostatic Microcomputed Tomography , 2006, Investigative radiology.

[4]  F. Lee,et al.  Imaging Efficacy of a Hepatocyte-Selective Polyiodinated Triglyceride for Contrast-Enhanced Computed Tomography , 2001, American journal of therapeutics.

[5]  Maria Drangova,et al.  Prospective respiratory-gated micro-CT of free breathing rodents. , 2005, Medical physics.

[6]  T. Winter,et al.  Low-attenuation oral GI contrast agents in abdominal-pelvic computed tomography , 2005, Abdominal Imaging.

[7]  L. Feldkamp,et al.  Practical cone-beam algorithm , 1984 .

[8]  N. Otsu.  A threshold selection method from gray level histograms , 1979 .

[9]  Jamey P Weichert,et al.  Imaging of murine liver tumor using microCT with a hepatocyte-selective contrast agent: accuracy is dependent on adequate contrast enhancement. , 2004, The Journal of surgical research.

[10]  H. McLeod,et al.  A mouse model for developing treatment for secondary liver tumors. , 2005, International journal of oncology.

[11]  K. Camphausen,et al.  Radiation therapy to a primary tumor accelerates metastatic growth in mice. , 2001, Cancer research.

[12]  R. Counsell,et al.  Polyiodinated triglyceride lipid emulsions for use as hepatoselective contrast agents in CT: effects of physicochemical properties on biodistribution and imaging profiles. , 2000, Investigative radiology.

[13]  M. Eliasziw,et al.  Statistical methodology for the concurrent assessment of interrater and intrarater reliability: using goniometric measurements as an example. , 1994, Physical therapy.

[14]  Robert M. Hoffman,et al.  The multiple uses of fluorescent proteins to visualize cancer in vivo , 2005, Nature Reviews Cancer.

[15]  H. Shimada,et al.  Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Tischler,et al.  MicroCT for high‐resolution imaging of ectopic pheochromocytoma tumors in the liver of nude mice , 2006, International journal of cancer.

[17]  F. Lee,et al.  Lipid-based blood-pool CT imaging of the liver. , 1998, Academic radiology.

[18]  Aaron Fenster,et al.  Three-dimensional high-frequency ultrasound imaging for longitudinal evaluation of liver metastases in preclinical models. , 2005, Cancer research.

[19]  Maria Drangova,et al.  Fast Retrospectively Gated Quantitative Four-Dimensional (4D) Cardiac Micro Computed Tomography Imaging of Free-Breathing Mice , 2007, Investigative radiology.

[20]  John D Hazle,et al.  Design and performance characteristics of a digital flat-panel computed tomography system. , 2006, Medical physics.

[21]  H. Withers,et al.  Repair kinetics of mouse lung. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  H. Thames,et al.  Repair rate in mouse lung after clinically relevant radiation doses per fraction. , 1995, Radiation research.

[23]  M. Dewhirst,et al.  Use of in vivo bioluminescence imaging to predict hepatic tumor burden in mice. , 2004, The Journal of surgical research.

[24]  R. Price,et al.  Intraperitoneal administration of an iodine-based contrast agent to improve abdominal micro-computed tomography imaging in mice. , 2005, Contemporary topics in laboratory animal science.

[25]  R. Maronpot,et al.  Method for Determining Whether the Number of Hepatocytes in Rat Liver is Increased after Treatment with the Peroxisome Proliferator Gemfibrozil , 1997, Journal of applied toxicology : JAT.

[26]  Peter Choyke,et al.  Current Advances in Molecular Imaging: Noninvasive in Vivo Bioluminescent and Fluorescent Optical Imaging in Cancer Research , 2003, Molecular imaging.

[27]  J. Oosterhuis,et al.  Cervical tissue shrinkage by formaldehyde fixation, paraffin wax embedding, section cutting and mounting , 2004, Virchows Archiv A.

[28]  I. Macdonald,et al.  Early interactions of cancer cells with the microvasculature in mouse liver and muscle during hematogenous metastasis: videomicroscopic analysis , 1993, Clinical & Experimental Metastasis.

[29]  W. Greco,et al.  High-Resolution Magnetic Resonance Imaging of the Efficacy of the Cytosine Analogue 1-[2-C-Cyano-2-deoxy-β-d-arabino-pentofuranosyl]-N4-palmitoyl Cytosine (CS-682) in a Liver-Metastasis Athymic Nude Mouse Model , 2003 .

[30]  I. Fidler,et al.  Selection of successive tumour lines for metastasis. , 1973, Nature: New biology.

[31]  R. Counsell,et al.  Polyiodinated triglyceride analogs as potential computed tomography imaging agents for the liver. , 1995, Journal of medicinal chemistry.

[32]  Charles Keller,et al.  Practical Vessel Imaging by Computed Tomography in Live Transgenic Mouse Models for Human Tumors , 2005, Molecular imaging.

[33]  David W Holdsworth,et al.  Time-Course Characterization of the Computed Tomography Contrast Enhancement of an Iodinated Blood-Pool Contrast Agent in Mice Using a Volumetric Flat-Panel Equipped Computed Tomography Scanner , 2006, Investigative radiology.

[34]  M. Brechbiel,et al.  Dynamic micro-magnetic resonance imaging of liver micrometastasis in mice with a novel liver macromolecular magnetic resonance contrast agent DAB-Am64-(1B4M-Gd)(64). , 2001, Cancer research.

[35]  Wolfhard Semmler,et al.  Volumetric computed tomography (VCT): a new technology for noninvasive, high-resolution monitoring of tumor angiogenesis , 2004, Nature Medicine.

[36]  A Fenster,et al.  Volume measurement variability in three-dimensional high-frequency ultrasound images of murine liver metastases , 2006, Physics in medicine and biology.